Concepedia
Statistics
Publications
15
Citations
1.1K
H-Index
13
Active since
1985
Affiliations
University of Sheffield(Current)
Royal Hallamshire Hospital
German Rheumatism Research Centre
Chapel Allerton Hospital
GlaxoSmithKline (United Kingdom)
D E Bax is an author at University of Sheffield specializing in rheumatology, rheumatoid arthritis, and autoimmunity.
Publications per year
1985–2009
Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis.
Nicola Peel, David Moore, N.A. Barrington et al. · Annals of the Rheumatic Diseases · 1995 · 379 citations · Full text
Medicine, Orthopedic Surgery, Radiology +17
Sulphasalazine for rheumatoid arthritis: toxicity in 774 patients monitored for one to 11 years.
R S Amos, T Pullar, D E Bax et al. · BMJ · 1986 · 145 citations · Full text
Pharmacy, Pharmacology, Pharmacotherapy +12
Prevention of Bone Loss with Risedronate in Glucocorticoid-Treated Rheumatoid Arthritis Patients
Richard Eastell, J. P. Devogelaer, Nicola Peel et al. · Osteoporosis International · 2000 · 134 citations
Medicine, Clinical Sciences, Internal Medicine +14
Combined effects of three independent SNPs greatly increase the risk estimate for RA at 6q23
Gisela Orozco, Anne Hinks, Xiayi Ke et al. · Human Molecular Genetics · 2009 · 102 citations · Full text
Life Sciences, Genetics, Molecular Genetics +15
Sulphasalazine: a safe, effective agent for prolonged control of rheumatoid arthritis. A comparison with sodium aurothiomalate.
D E Bax, R S Amos · Annals of the Rheumatic Diseases · 1985 · 89 citations
Medicine, Internal Medicine, Pharmacotherapy +10
1–5 of 15